Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Could Amgen's Next Drug Be Worth $100 Billion?
Investopedia
Sat, 03/14/15 - 02:35 pm
Amgen
evolocumab
Data on investigational cholesterol-lowering meds to be presented at cardiology meeting
Medical Marketing and Media
Thu, 03/12/15 - 10:14 pm
PCSK9 inhibitors
Amgen
Repatha
The 4 Biggest Biotech Stocks In The Market
Yahoo/Benzinga
Thu, 03/12/15 - 07:55 am
biotech
Celgene
Regeneron
Biogen Idec
Amgen
Gilead Sciences
Amgen: The biotech that's getting on the biosimilar R&D bandwagon
BioPharma Dive
Wed, 03/11/15 - 08:38 am
Amgen
biosimilars
Zarxio
Neupogen
Onyx field reps spared in Amgen's 300-job bloodletting
Fierce Pharma Marketing
Wed, 03/11/15 - 08:20 am
ONYX Pharmaceuticals
Amgen
M&A
layoffs
drug reps
Amgen to cut about 300 jobs, close one building in South San Francisco
Marketwatch
Tue, 03/10/15 - 07:02 pm
Amgen
layoffs
Amgen, Inc. Plans For Biosimilar Launches
Bidness Etc.
Tue, 03/10/15 - 08:21 am
Amgen
biosimilars
Roche
AbbVie
Neupogen
First Copycat Biotech Drug Spurs $250B Obamacare Savings
Forbes
Sat, 03/7/15 - 11:16 am
Zarxio
Novartis
biologics
Amgen
Neupogen
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
Novartis wins approval for first U.S. biosimilar drug
Yahoo/Reuters
Fri, 03/6/15 - 10:01 am
Novartis
FDA
Neupogen
Zarxio
Sandoz
Amgen
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Fierce Pharma
Tue, 03/3/15 - 08:05 am
ONYX Pharmaceuticals
Amgen
Velcade
Kyprolis
Multiple Myeloma
Is This Amgen's Next Big Thing?
Investopedia
Tue, 03/3/15 - 07:55 am
Amgen
evolocumab
biosimilars
Amgen hands off an IL-15 drug--strings attached--for upstart effort on celiac disease
Fierce Biotech
Mon, 03/2/15 - 08:14 am
Amgen
celiac disease
AMG 714
Genmab
Amgen's Kyprolis Outperforms Rival Drug In Study
Forbes
Mon, 03/2/15 - 08:05 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Novartis AG, Amgen, Inc. Tussle Over Neupogen Biosimilar Continues
Bidness Etc.
Sun, 03/1/15 - 11:40 am
Novartis
Amgen
biosimilars
Neupogen
Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar
Fierce Biotech
Thu, 02/26/15 - 10:26 am
Amgen
AMG416
Sensipar
secondary hyperparathyroidism
No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
Forbes
Thu, 02/19/15 - 07:53 am
Sanofi
Amgen
PCSK9 inhibitors
drug pricing
AbbVie: Amgen Circa 2011?
Barron's
Tue, 02/17/15 - 04:40 pm
Amgen
AbbVie
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Pages
« first
‹ previous
…
54
55
56
57
58
59
60
61
62
…
next ›
last »